UDI Requirements for Small Medical Device Manufacturers: What's Actually Required and When

UDI Compliance Is Not Optional — Even for Small Manufacturers

If you are a startup founder or a VP of Quality at a small medical device company, there is a good chance UDI compliance has been sitting at the bottom of your regulatory to-do list. That is a costly mistake. The FDA's Unique Device Identification system is a fully enforced requirement under 21 CFR Part 830, and non-compliance can delay your 510(k) clearance, block your device from hospital purchasing systems, and expose you to enforcement action. This post cuts through the noise and tells you exactly what is required, when it applies, and what small manufacturers often get wrong.

The Regulatory Foundation: What the Rule Actually Says

The UDI Final Rule, codified at 21 CFR Part 830, requires manufacturers to:

• Assign a UDI to each device they introduce into U.S. commerce
• Label each device with the UDI in both human-readable interpretation (HRI) and automatic identification and data capture (AIDC) technology — typically a barcode or RFID
• Submit device information to FDA's Global Unique Device Identification Database (GUDID)
• Maintain records associating the UDI with the device

The UDI itself consists of two parts: the Device Identifier (DI), which is static and identifies the specific version or model, and the Production Identifier (PI), which carries variable information such as lot number, serial number, manufacture date, and expiration date as applicable. Accredited issuing agencies — currently GS1, HIBCC, and ICCBBA — assign the DI portion of the UDI under FDA-recognized systems.

Compliance Dates by Device Class: Where Small Manufacturers Often Miscalculate

FDA phased in UDI requirements based on device class, and all compliance deadlines have now passed for Class III, II, and most Class I devices. Here is where many small manufacturers stumble: they assume that because their device is a low-risk Class I product, the rules are lighter. That assumption is only partially correct.

Class I Devices

Class I devices that are not exempt were required to comply by September 24, 2020. However, 21 CFR 830.100(a) includes an exemption for Class I devices that are not required to be tracked under Section 519(e) of the FD&C Act and are not intended for use more than once. If your Class I device does not fall under a specific exemption, you are required to label with a UDI and submit data to GUDID. Many founders incorrectly assume a broad Class I exemption exists. It does not.

Implantable, Life-Supporting, and Life-Sustaining Devices

These devices — regardless of class — carry a direct marking requirement under 21 CFR 830.20. If your device is implantable, it must bear a permanent UDI mark directly on the device itself, not just the packaging. This is separate from labeling requirements and is an area where startups developing orthopedic implants, cardiovascular devices, and neurostimulators frequently fall short during pre-submission review.

GUDID Submission: The Step Most Small Manufacturers Underestimate

GUDID submission is not a one-time checkbox. Under 21 CFR 830.300 through 830.310, manufacturers must submit and maintain accurate device records in GUDID. This includes updating records when device information changes — a new sterilization method, a labeling revision, a change in device size or configuration. Each distinct version or model of a device requires its own DI and its own GUDID record.

FDA's guidance document, 'Unique Device Identification: Policy Regarding Compliance Dates for Class I Devices and Certain Unclassified Devices' (issued 2016), along with the more comprehensive 'UDI: A Guide for Carton and Label Requirements' guidance, provides detailed direction on labeling format and content. Manufacturers should also reference the GUDID Data Elements document available on FDA's website, which specifies the more than 60 data fields that may apply to a given device record.

Common Compliance Gaps We See at Small Companies

Across our work with device startups and growing manufacturers, the following gaps appear most frequently:

• Labeling the packaging but not the device itself for implantable products subject to direct marking requirements
• Submitting an incomplete GUDID record that omits required fields such as MRI safety information, latex content, or device size
• Failing to update GUDID when a 510(k) change triggers a new DI assignment
• Using a non-accredited issuing agency or generating a UDI internally without going through GS1, HIBCC, or ICCBBA
• Confusing device identifier assignment with UDI label implementation — these are distinct activities with different timelines in a product launch plan

When UDI Intersects with Your Submission Strategy

UDI compliance is not just an operational matter — it is a submission matter. FDA reviewers expect to see the UDI format and labeling strategy addressed in your 510(k) or De Novo submission. Under 21 CFR 807.87, the 510(k) must include proposed labeling, and FDA will flag submissions where UDI labeling is absent or inconsistent with GUDID records. Building UDI planning into your regulatory strategy from the beginning — not as an afterthought — avoids requests for additional information that delay clearance.

Take the Right Steps Before You Launch

UDI compliance is achievable for small manufacturers, but it requires deliberate planning, the right issuing agency relationship, and a clear understanding of which exemptions do and do not apply to your specific device. Getting it wrong does not just create a compliance problem — it can disrupt hospital procurement, complicate post-market surveillance, and become a flag during FDA inspections under 21 CFR Part 820.

If you are unsure where your device stands on UDI compliance — or if you are building your regulatory pathway and want to get UDI right the first time — the regulatory team at ADB Consulting and CRO Inc. is ready to help. Book a free discovery call at adbccro.com to speak directly with our regulatory affairs practice group. We work with device startups and growing manufacturers every day on exactly these challenges, and we will give you a straight answer on what you need to do and when.

For related guidance, see our annual registration renewal service.